Marta Mechelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marta Mechelli has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Elisabetta Manuali
Istituto Zooprofilattico Sperimentale dell’Umbria e delle Marche, Via G. Salvemini 1, 06126 Perugia, Italy
1 shared publication - Elisabetta Razzuoli
Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, 16129 Genoa, Italy
1 shared publication - Elvio Lepri
Department of Veterinary Medicine, University of Perugia, Perugia, Italy
1 shared publication - Filippo Dell’aNno
National Reference Center of Veterinary and Comparative Oncology (CEROVEC), Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, Genoa, Italy
1 shared publication - Floriana Fruscione
National Reference Center of Veterinary and Comparative Oncology (CEROVEC), Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, Piazza Borgo Pila 39/24, 16129 Genoa, Italy
1 shared publication - Giuseppe Giglia
University of Perugia, Perugia, Italy
1 shared publication
Latest Publications
- Open Access
- 9 January 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (1) , 64
Epidemiology of Splenic Lesions in Dogs Undergoing Splenectomy—Pathological Characterization and Risk Factors
Splenic lesions are common in dogs and can have important clinical implications due to the risk of rupture causing life-threatening hemorrhage, or, for neoplastic lesions, potential metastatic spread. This retrospective study analyzed 682 canine spleen samples submitted to the Regional Canine Cancer Registry in Umbria, Italy, between 2014 and 2023, aiming to characterize lesion types and explore associations with demographic factors and clinical outcomes. Lesions were classified as neoplastic or non-neoplastic. Non-neoplastic lesions were predominant (54.3%), mainly nodular hyperplasia, hematoma, and congestion, while neoplastic lesions accounted for 45.7%, with hemangiosarcoma (HSA) being the most frequent neoplasm (54.5%), followed by other sarcomas, lymphomas, and rare tumors. The mean age at diagnosis was 10.4 years, and medium-sized dogs living in urban areas were most affected. No significant differences in lesion type were observed between sexes or between purebred and mixed-breed dogs, although purebreds were more represented overall. HSA risk varied by size, sex, and breed, with large dogs and certain pure breeds showing elevated risk. Survival analysis revealed markedly reduced outcomes for dogs with HSA. These findings emphasize the utility of histopathologic diagnosis in guiding clinical management and provide insight into the epidemiology and prognosis of splenic lesions in dogs.
- 9 January 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (1) , 64
Open AccessEpidemiology of Splenic Lesions in Dogs Undergoing Splenectomy—Pathological Characterization and Risk Factors
Splenic lesions are common in dogs and can have important clinical implications due to the risk of rupture causing life-threatening hemorrhage, or, for neoplastic lesions, potential metastatic spread. This retrospective study analyzed 682 canine spleen samples submitted to the Regional Canine Cancer Registry in Umbria, Italy, between 2014 and 2023, aiming to characterize lesion types and explore associations with demographic factors and clinical outcomes. Lesions were classified as neoplastic or non-neoplastic. Non-neoplastic lesions were predominant (54.3%), mainly nodular hyperplasia, hematoma, and congestion, while neoplastic lesions accounted for 45.7%, with hemangiosarcoma (HSA) being the most frequent neoplasm (54.5%), followed by other sarcomas, lymphomas, and rare tumors. The mean age at diagnosis was 10.4 years, and medium-sized dogs living in urban areas were most affected. No significant differences in lesion type were observed between sexes or between purebred and mixed-breed dogs, although purebreds were more represented overall. HSA risk varied by size, sex, and breed, with large dogs and certain pure breeds showing elevated risk. Survival analysis revealed markedly reduced outcomes for dogs with HSA. These findings emphasize the utility of histopathologic diagnosis in guiding clinical management and provide insight into the epidemiology and prognosis of splenic lesions in dogs.